摘要
目的在瘢痕疙瘩患者进行90Sr同位素敷贴治疗前,按照温哥华瘢痕量表进行评分,推断治疗效果,合理选择适应症。方法选取2008年1月至2013年1月在本院皮肤科及外科门诊确诊的瘢痕疙瘩患者105例,按照温哥华瘢痕量表根据色泽、厚度、血管分布、柔软度进行评分,分为两组(A组0~8分,B组9~15分),采用90Sr同位素敷贴治疗,治疗后随访6~12个月,进行疗效评价。结果在131例瘢痕疙瘩患者中,痊愈率48.09%;好转率51.91%;总有效率100%。其中A组剂量30.12±3.15Gy,痊愈率62.69%,不良反应发生率16.42%。B组剂量44.16±5.56Gy,痊愈率32.81%,不良反应发生率48.48%。经spss16.0统计学软件处理,差异有统计学意义。结论在瘢痕疙瘩患者进行90Sr同位素敷贴治疗前,按照温哥华瘢痕量表进行评分,根据量表评分来选择合适患者治疗,是一种简单、有效且较为准确的方法。
Objective To explore the clinical curative effects of the treatment of keloids with90 Sr radiation and to choose adaptive indications by Vancouver scale. Methods 105 patients with 131 keloids were involved in this study. These keloids scored by VSS in color and luster,thickness,vascularity,softness and were divided into two groups（ Group A 0 ~ 8,Group B 9 ~ 15）. The patients were followed up for 6 to 12 months after the treatment with90 Sr radiation for efficacy evaluation. Results The cure rate of 131 keloids was 48. 09%,and the improve rate was 51. 91%,and the total effective rate was 51. 91%. The radiation dose in Group A was 23. 5 ± 8. 2Gy,and the cure rate was 62. 69%,the adverse effect rate was 16. 42%. The radiation dose in Group B was 35. 1 ± 6. 2Gy,and the cure rate was 32. 81%,the adverse effect rate was 48. 48%. Conclusion Vancouver scale is a simple,effect and accurate method to select the appropriate keloid patients for90 Sr applicator therapy.
出处
《标记免疫分析与临床》
CAS
2015年第3期221-223,共3页
Labeled Immunoassays and Clinical Medicine
